Stockscreener 앱 받기
2.8675
0.35%
-0.0125
Xeris Biopharma Holdings Inc 주식(XERS)의 최신 뉴스
Principal Financial Group Inc. Sells 10,992 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings Inc [XERS] stock for 10,147 USD was bought by Schmid John P. - Knox Daily
Xeris Biopharma Holdings Inc [XERS] Revenue clocked in at $181.41 million, up 21.70% YTD: What’s Next? - The DBT News
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) most popular amongst individual investors who own 53% of the shares, institutions hold 43% - Yahoo Finance
XERS: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Healthy Upside Potential: Xeris Biopharma Holdings Inc (XERS) - SETE News
The Potential Rise in the Price of Xeris Biopharma Holdings Inc (XERS) following insiders activity - Knox Daily
Xeris Biopharma Holdings Inc (XERS) requires closer examination - US Post News
Trading Day Review: Xeris Biopharma Holdings Inc (XERS) Gains Momentum, Closing at 2.67 - The Dwinnex
Allspring Global Investments Holdings LLC Boosts Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Could Be Riskier Than It Looks - Simply Wall St
Taking a look at what insiders are doing to gauge the Xeris Biopharma Holdings Inc (XERS)’s direction - Knox Daily
Xeris Biopharma Holdings Inc (XERS) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
A History of Outperforming Analyst Forecasts and Beating the Odds: Xeris Biopharma Holdings Inc (XERS) - SETE News
Examining Xeris Biopharma Holdings Inc (XERS) stock is warranted - US Post News
Xeris Biopharma Holdings Inc [XERS] Records 200-Day SMA of $2.27 - Knox Daily
Xeris Biopharma Holdings Inc (XERS) shows promising results - US Post News
Understanding the Risks of Investing in Xeris Biopharma Holdings Inc (XERS) - Knox Daily
Trading Day Triumph: Xeris Biopharma Holdings Inc (XERS) Ends at 2.88, a 2.86 Surge/Plunge - The Dwinnex
The time has not yet come to remove your chips from the table: Xeris Biopharma Holdings Inc (XERS) - SETE News
This Data Shows Just How Strong Xeris Biopharma Holdings Inc (NASDAQ: XERS) Stock Is - Stocks Register
Xeris Biopharma Holdings Inc’s Shares Reel: 48.97% Quarterly Revenue Decline Amid 432.84M Market Cap - The InvestChronicle
Xeris Biopharma Holdings Inc [XERS] Records 50-Day SMA of $2.35 - Knox Daily
Xeris Biopharma Holdings Inc (XERS) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Xeris to Participate in Upcoming Investor Conferences - StockTitan
Xeris to Participate in Upcoming Investor Conferences - Business Wire
Gaining Ground: Xeris Biopharma Holdings Inc (XERS) Closes Lower at 2.70, Down -0.74 - The Dwinnex
How should investors view Xeris Biopharma Holdings Inc (XERS)? - US Post News
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Sold by California State Teachers Retirement System - Defense World
Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying - MSN
Investing in Xeris Biopharma Holdings Inc (XERS): What You Must Know - Knoxdaily.com
XERS (Xeris Biopharma Holdings) EPS (Basic) : $-0.42 (TTM As of Jun. 2024) - GuruFocus.com
A new trading data show Xeris Biopharma Holdings Inc (XERS) is showing positive returns. - SETE News
Xeris Biopharma Holdings (FRA:2B30) Cash-to-Debt : 0.29 (As of Jun. 2024) - GuruFocus.com
Xeris Biopharma Holdings (FRA:2B30) Long-Term Debt & Capita - GuruFocus.com
Xeris Biopharma (NASDAQ:XERS) Rating Reiterated by HC Wainwright - Defense World
Price T Rowe Associates Inc. MD Boosts Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings (FRA:2B30) Momentum Rank : 1 (As of Aug. 16, 2024) - GuruFocus.com
Brokers Offer Predictions for Xeris Biopharma Holdings, Inc.’s Q3 2024 Earnings (NASDAQ:XERS) - Defense World
Q3 2024 EPS Estimates for Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Decreased by Analyst - MarketBeat
Insider Buying: Schmid John P., Xeris Biopharma Holdings Inc [XERS] Director invested 4,515 shares - Knox Daily
Xeris Biopharma Holdings (FRA:2B30) Enterprise Value : €553.2 Mil (As of Sep. 03, 2024) - GuruFocus.com
Xeris Biopharma Holdings (FRA:2B30) PS Ratio : 1.91 (As of Aug. 16, 2024) - GuruFocus.com
HC Wainwright Reaffirms "Buy" Rating for Xeris Biopharma (NASDAQ:XERS) - MarketBeat
Equities Analysts Offer Predictions for Xeris Biopharma Holdings, Inc.'s FY2027 Earnings (NASDAQ:XERS) - MarketBeat
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) to Post FY2027 Earnings of $0.27 Per Share, HC Wainwright Forecasts - Defense World
XERS (Xeris Biopharma Holdings) GF Value : $3.40 (As of Aug. 15, 2024) - GuruFocus.com
XERSXeris Biopharma Holdings, Inc. Latest Stock News & Market Updates - StockTitan
XERS: A Tale of Ups & Downs – -13.90% loss in 6 Months, 2.42% in 30 Days - The InvestChronicle
Xeris Biopharma director buys $10.1k in company shares - Investing.com India
Xeris Biopharma director buys $10.1k in company shares By Investing.com - Investing.com Australia
More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying - Benzinga
Xeris Biopharma director buys $10.1k in company shares - Investing.com
Xeris Biopharma director buys $10.1k in company shares By Investing.com - Investing.com Canada
Xeris Biopharma Holdings Inc [XERS] Investment Guide: What You Need to Know - Knox Daily
Xeris Biopharma director buys $10.1k in company shares By Investing.com - Investing.com UK
Investor’s Delight: Xeris Biopharma Holdings Inc (XERS) Closes Weak at 2.25, Down -3.02 - The Dwinnex
Vanguard Group Inc. Purchases 519,897 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat
Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying - Benzinga
Simplicity Wealth LLC Makes New Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Vanguard Group Inc. Grows Stock Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Director John P. Schmid Purchases 4,285 Shares - Defense World
Xeris Biopharma director purchases $10k worth of company stock By Investing.com - Investing.com Australia
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Director Buys $10,155.45 in Stock - MarketBeat
Xeris Biopharma director purchases $10k worth of company stock - Investing.com
Xeris Biopharma director purchases $10k worth of company stock By Investing.com - Investing.com UK
Wall Street analysts’ outlook for Xeris Biopharma Holdings Inc (XERS) - SETE News
Xeris Biopharma (NASDAQ:XERS) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - Defense World
Xeris Biopharma (NASDAQ:XERS) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
1.28%
1.94%
자본화:
|
볼륨(24시간):